|
Longmeadow Capital Partners purchased the
assets of Envoy Health in August of 2006. Envoy Health focuses
exclusively on diabetes management and care. As a national
provider of direct-to-consumer mail order diabetic testing supplies and
services, Envoy has been serving tens of thousands of diabetics since
1995.
Longmeadow along with a seasoned healthcare executive sponsored a
transaction to purchase the assets of a predecessor company and through
a series of acquisitions and organic marketing efforts quadrupled the
size of the Company.
Envoy was sold to Lincare, Inc. in May 2013.
Next
Next
|
